|Former Common name||Lrit2 KO|
|H-2 Haplotype||No Data|
|Strain description||No Data|
|Health Report||No Data|
|Symbol name||leucine-rich repeat, immunoglobulin-like and transmembrane domains 2|
|Common name||No Data|
|Symbol description||No Data|
|Research applications||No Data|
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
Cell Reports, 22, 3548-3561 (2018)
In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
RECIPIENT which wants to use the BIOLOGICAL RESOURCE is requested to contact the depositor (Dr. Takahisa Furukawa) and enter into a Material Transfer Agreement with Osaka University.
|Depositor||Furukawa, Takahisa (Institute for Protein Research, Osaka University)|
|Strain Status /